Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
2ww referral Routine referral / Haem A&G Annual monitoring in primary care Local Guidance for managing MGUS for primary care
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet
Monoclonal gammopathy of undetermined significance - Wikipedia
Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Kappa and Lambda Light Chains - HealthTree for Myeloma
Monoclonal Gammopathy of Undetermined Significance | IntechOpen
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Monoclonal Gammopathies of Undetermined Significance and Smoldering Multiple Myeloma | Oncohema Key
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Myeloma Explained | Haematology | Oncology | onthewards
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Frontiers | Game of Bones: How Myeloma Manipulates Its Microenvironment
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
